Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine in Non-dystrophic Myotonias
NCT02336477Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2011
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mexiletine in paramyotonia congenita (PMC), myotonia congenita (MC), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2011; status: completed.
02
Drugs
mexiletine
03
Conditions
paramyotonia congenita (PMC)myotonia congenita (MC)
Beyond the preview
Go deeper on NCT02336477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336477.